Trade Travere Therapeutics, Inc. - TVTX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.08 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 17.59 |
| Open | 17.34 |
| 1-Year Change | 219.34% |
| Day's Range | 17.34 - 18.38 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 17.59 | 1.27 | 7.78% | 16.32 | 17.64 | 16.32 |
| Apr 23, 2025 | 16.65 | 0.67 | 4.19% | 15.98 | 17.39 | 15.98 |
| Apr 22, 2025 | 15.84 | 0.80 | 5.32% | 15.04 | 16.04 | 15.04 |
| Apr 21, 2025 | 15.07 | 0.46 | 3.15% | 14.61 | 15.77 | 14.61 |
| Apr 17, 2025 | 14.87 | 0.40 | 2.76% | 14.47 | 14.90 | 14.43 |
| Apr 16, 2025 | 14.53 | 0.12 | 0.83% | 14.41 | 14.65 | 14.09 |
| Apr 15, 2025 | 14.87 | 0.49 | 3.41% | 14.38 | 15.04 | 14.38 |
| Apr 14, 2025 | 14.78 | 0.29 | 2.00% | 14.49 | 15.03 | 14.43 |
| Apr 11, 2025 | 14.42 | 1.34 | 10.24% | 13.08 | 14.61 | 13.08 |
| Apr 10, 2025 | 13.45 | -0.87 | -6.08% | 14.32 | 14.38 | 13.10 |
| Apr 9, 2025 | 14.31 | 0.87 | 6.47% | 13.44 | 14.94 | 12.87 |
| Apr 8, 2025 | 14.09 | -1.44 | -9.27% | 15.53 | 15.70 | 13.70 |
| Apr 7, 2025 | 15.11 | 0.81 | 5.66% | 14.30 | 15.72 | 13.91 |
| Apr 4, 2025 | 14.97 | -0.70 | -4.47% | 15.67 | 15.88 | 14.81 |
| Apr 3, 2025 | 16.51 | 0.08 | 0.49% | 16.43 | 17.21 | 15.93 |
| Apr 2, 2025 | 17.89 | 0.86 | 5.05% | 17.03 | 18.06 | 17.03 |
| Apr 1, 2025 | 17.39 | -0.50 | -2.79% | 17.89 | 18.84 | 17.31 |
| Mar 31, 2025 | 17.87 | -1.14 | -6.00% | 19.01 | 19.21 | 17.40 |
| Mar 28, 2025 | 19.63 | -0.61 | -3.01% | 20.24 | 20.36 | 19.42 |
| Mar 27, 2025 | 20.33 | -0.22 | -1.07% | 20.55 | 21.09 | 20.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Travere Therapeutics, Inc. Company profile
Travere Therapeutics (TVTX) is a US-based biopharmaceutical company that identifies, develops and delivers life-changing therapies to people suffering from rare diseases. The firm is headquartered in San Diego, California.
The company currently has four approved commercial therapies: Chenodal (chenodiol), Cholbam (cholic acid), Thiola (tiopronin), and Thiola EC (tiopronin) delayed-release tablets.
The rare diseases for which the company currently offers therapies are Peroxisomal Biogenesis Disorder-Zellweger Spectrum Disorder (PBD-ZSD), Cerebrotendinous Xanthomatosis (CTX), Focal Segmental Glomerulosclerosis (FSGS), IgA Nephropathy (IgAN), Classical Homocystinuria (HCU), Cystinuria, Bile Acid Synthesis Disorders (BASD), N-Glycanase 1 (NGLY1) Deficiency, and Alagille Syndrome (ALGS).
Travere Therapeutics shares trade on the NASDAQ Stock Exchange under the ticker symbol TVTX. The company was founded as Retrophin Inc. in February 2011 and became public in December 2012.As of August 2022, Travere Therapeutics does not pay a dividend.
You can follow the ups and downs of the Travere Therapeutics stock price at Capital.com. Always stay on top of the latest price developments with our live TVTX stock price chart.
| Industry: | Bio Therapeutic Drugs |
3611 Valley Centre Dr
Suite 300
SAN DIEGO
CALIFORNIA 92130
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com